Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $822.7850 (1.02%) ($822.7850 - $822.7850) on Mon. Dec. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.07% (three month average) | RSI | 71 | Latest Price | $822.7850(1.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 1.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(53%) IBB(51%) SPLV(48%) XLV(48%) XLU(45%) | Factors Impacting REGN price | REGN will decline at least -0.535% in a week (0% probabilities). VXX(-36%) ONLN(-36%) EDOC(-36%) USO(-35%) XLE(-28%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.535% (StdDev 1.07%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $813.98(1.08%) | 10 Day Moving Average | $806.98(1.96%) | 20 Day Moving Average | $806.33(2.04%) | To recent high | -2.7% | To recent low | 6.2% | Market Cap | $87.239b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |